These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Sensitivity to antibiotics of Escherichia coli strains isolated from children admitted to the "Sf. Ioan" clinical emergency hospital for children in Galaţi during 2005-2006]. Author: Florea C. Journal: Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):37-44. PubMed ID: 18441957. Abstract: The urinary tract infections (UTI) in children represent an important problem both because of their frequency, particularly in small children, and because of the morbidity they generate, sometimes on a long term. Escherichia coli represents the etiologic cause of 80% of these urinary infections. In 2005, 66 E. coli strains were analyzed and, in 2006, 69 E. coli strains were analyzed, coming from significantly positive urocultures > 10(5) UFC/ml. The E. coli strains were identified by the morphologic, culture and biochemical characters. The testing of the sensitivity to antibiotics was performed by the disk-diffusimetry method on Mueller-Hinton agar, and the reading was done visually, according to standards recommended by the suppliers of antibiotics disks. The results were as follows: Sensitivity to antibiotics, even though it was only tested for two years, has recorded slight decreases for some of the antibiotics (beta-lactams simple or in association with beta-lactamase inhibitors). This situation is probably due to a wrong treatment with these drugs, which made E. coli acquire the resistance characters. For cephalosporins, a decrease in the sensitivity was noticed above all for cephalosporins in generations 1 and 2, leaving those in generation 3 with an increased sensitivity. An important decrease was also recorded for the combination trimethoprim-sulfamethoxazole. Still, some urinary strains of E. coli remain sensitive to drugs such as: colistin, aminoglycosides, cephalosporins (particularly the third generation), fosfomycin, imipenem and the fluoroquinolones.[Abstract] [Full Text] [Related] [New Search]